Brind.

Foundation Medicine and Fulgent Genetics announced a precision diagnostics partnership and received CE mark for diagnostic services in Europe.

3 reports, 2 independent Updated Jul 1
Gone quiet Reached 2 outlets in its first 24 hours
Reports
3
Developments
1
Repetition
67%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Foundation Medicine and Fulgent Genetics announced a precision diagnostics partnership and received CE mark for diagnostic services in Europe.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • GuruFocus.comFulgent Genetics Inc (FLGT) Q2 2025 Earnings Call Highlights: Strong Core Revenue Growth Amid ... Release Date: August 01, 2025 For the complete transcript of the earnings call, please refer to the f
  • Business WireFulgent Genetics Receives EU CE Mark for FulgentExome & FulgentPLM EL MONTE, Calif., July 17, 2025--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent," or the "Company"), a technology-
1 more outlet ran the same wire story